The company is the largest production base of anticancer drugs, the state designated narcotics manufacturer and is an hi-tech enterprise recognized by Science and Technology Committee with a post-doctoral research station. It is also a national "863 Plan" industrial base. The main products are: oncology, cardiovascular medicine, narcotic pain medicine etc. Some numbers of the products have passed national GMP and U.S. FDA certification. Through technology transfer, joint innovation, self-development and other forms of development, the company has now owned more than 90 new drug certificates including class 1 and class 2 certificates. Four of the company’s projects have been included in the national "863 Plan". A number of the company developed patented drugs and innovative drugs are under or will be under clinical trials.
38 Huanghe R. Lianyungang E.D.A. Jiangsu
Lianyungang; Jiangsu; Postal Code: 222000
Contact Details: Purchase the Jiangsu Hengrui Medicine Co., Ltd report to view the information.
EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.Request a demo of the EMIS service
To view more information, Request a demonstration of the EMIS service